Latest AI and machine learning research in primary care for healthcare professionals.
Parkinson's disease (PD) is the fastest growing neurological disorder worldwide and is projected to affect unprecedented numbers of individuals by 2050. At the same time, PD research is undergoing a profound conceptual transformation. Advances in molecular neuropathology, genetics, biomarker science, artificial intelligence, multimodal imaging, digital medicine, and precision therapeutics are resh...
BACKGROUND: Diabetes, hypertension, and dyslipidemia are major risk factors for cardiovascular, neurological, renal, and pulmonary diseases, yet clinically accessible molecular mediators linking these cardiometabolic conditions to downstream complications remain unclear. METHODS: We analyzed plasma proteomic data from 53,030 UK Biobank participants with longitudinal follow-up. Mediation analysis e...
BACKGROUND AND AIM: The burden of both psychiatric symptoms (anxiety and/or depression) and hypertension poses significant public health challenges in...
OBJECTIVE: This study aimed to develop a machine learning (ML) framework to predict incident type 2 diabetes mellitus (T2DM) using routinely available...
BACKGROUND: Automated phlebotomy has the potential to improve patient outcomes and address phlebotomist workforce challenges. The Autonomous Blood Dra...
Triboelectric nanogenerators (TENGs) have emerged as promising platforms for self-powered sensing and real-time biomechanical monitoring. However, cur...
The advent of novel disease-modifying therapeutics for spinal muscular atrophy (SMA) increased life expectancy with better motor function and potentia...
Artificial intelligence (AI) has achieved remarkable success in the diagnosis of Alzheimer's disease (AD) in the literature, where many of the models ...
Prakriti, the Ayurvedic concept of individual somatic constitution, forms the foundation for personalized preventive and therapeutic strategies by cla...
BACKGROUND: Artificial intelligence-enabled electrocardiography (AI-ECG) has emerged as a promising tool for identifying patients with atrial fibrilla...
Large-scale ecological restoration is increasingly promoted as a strategy for environmental sustainability, but its implications for population health...
AIMS: Some studies have explored associations between physical activity (PA) and hypoglycaemia in real-life in type 1 diabetes (T1D) but without fully...
BACKGROUND: Adult Attention-Deficit/Hyperactivity Disorder (ADHD) is under-recognized in professional drivers, yet it poses significant safety risks. ...
BackgroundMachine learning offers new avenues for complementing traditional epidemiological approaches by analyzing routinely collected, population-ba...
OBJECTIVE: To develop a predictive model for coronary atherosclerosis progression in patients with type 2 diabetes mellitus (T2DM) based on Artificial...
OBJECTIVE: Research on the use of portable fundus cameras utilizing artificial intelligence (AI) for diabetic retinopathy (DR) screening in primary ca...
Virtual screening (VS) stands as a cornerstone of early-stage drug discovery, yet long-standing hurdles-including prohibitive computational cost and l...
Diabetes affects an estimated 828 million people worldwide; prevalence is growing rapidly in low- and middle-income countries (LMICs), with major heal...
AIM: To develop and validate machine learning models for clinically applicable risk stratification of postpartum hemorrhage (PPH) in vaginal delivery,...
Driven by changes in lifestyle and environmental factors, the global incidence of cancer is steadily increasing, which has established it as a leading...